October 19, 2023- According to Roche CEO Thomas Schinecker: “The company achieved good results in the first nine months of 2023, more than compensating for the expected decline in demand for COVID-19 products. Our Group sales excluding COVID-19 products continued to grow strongly by +9% at constant exchange rates.”
Notable sales statistics include:
- Group sales grew by 1% at constant exchange rates (CER) in the first nine months
- Excluding COVID-19 products, group sales increased by 9%